Staels, Frederik
Lorenzetti, Flaminia
De Keukeleere, Kerstin
Willemsen, Mathijs
Gerbaux, Margaux
Neumann, Julika
Tousseyn, Thomas
Pasciuto, Emanuela
De Munter, Paul
Bossuyt, Xavier
Gijsbers, Rik
Liston, Adrian
Humblet-Baron, Stephanie
Schrijvers, Rik http://orcid.org/0000-0002-4261-6220
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (11B5520N, 11C3521N, 1805518N)
KU Leuven (C12/16/024)
Article History
Received: 28 March 2022
Accepted: 27 June 2022
First Online: 13 July 2022
Declarations
:
: The study was conducted in accordance with the principles of the Helsinki Declaration and approved by the ethics committee of the University of Leuven (s58466). Written informed consent was obtained from patients and healthy control subjects.
: Written informed consent for the publication of this research was obtained from the study participants.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. RS is member of the European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (Project ID No 739543).